Association Studies of Serum Levels of TNF- α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts

References

• Bagcchi S. WHO’s Global Tuberculosis Report 2022. Lancet Microbe. 2023;4(1):e20. doi:10.1016/S2666-5247(22)00359-7
   PubMedGoogle Scholar
• Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. 2020;11:2006. doi:10.3389/fimmu.2020.02006
   PubMed Web of Science ®Google Scholar
• Pagaduan J, Altawallbeh G. Advances in TB testing. Adv Clin Chem. 2023;115:33–62.
   PubMedGoogle Scholar
• Cubillos-Angulo J, Arriaga M, Silva E, et al. Polymorphisms in TLR4 and TNFA and risk of mycobacterium tuberculosis infection and development of active disease in contacts of tuberculosis cases in brazil: a prospective cohort study. Clinl Infect Dis. 2019;69(6):1027–1035. doi:10.1093/cid/ciy1001
   PubMed Web of Science ®Google Scholar
• Gong W, Wu X. Differential diagnosis of latent tuberculosis infection and active tuberculosis: a key to a successful tuberculosis control strategy. Front Microbiol. 2021;12:745592. doi:10.3389/fmicb.2021.745592
   PubMed Web of Science ®Google Scholar
• Chai Q, Lu Z, Liu C. Host defense mechanisms against Mycobacterium tuberculosis. Cell Mol Life Sci. 2020;77(10):1859–1878. doi:10.1007/s00018-019-03353-5
   PubMed Web of Science ®Google Scholar
• Zhou J, Lv J, Carlson C, et al. Mycobacterium tuberculosisTrained immunity contributes to the prevention of infection, a novel role of autophagy. Emerging Microbes Infect. 2021;10(1):578–588. doi:10.1080/22221751.2021.1899771
   PubMed Web of Science ®Google Scholar
• Kaufmann S, Dorhoi A. Inflammation in tuberculosis: interactions, imbalances and interventions. Curr Opini Immunol. 2013;25(4):441–449. doi:10.1016/j.coi.2013.05.005
   PubMed Web of Science ®Google Scholar
• Carabalí-Isajar M, Rodríguez-Bejarano O, Amado T, et al. Clinical manifestations and immune response to tuberculosis. World J Microbiol Biotechnol. 2023;39(8):206. doi:10.1007/s11274-023-03636-x
   PubMed Web of Science ®Google Scholar
• Sudbury E, Clifford V, Messina N, Song R, Curtis N. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: a systematic review. J Infect. 2020;81(6):873–881. doi:10.1016/j.jinf.2020.09.032
   PubMed Web of Science ®Google Scholar
• Zhang B, Xiao L, Qiu Q, Miao L, Yan S, Zhou S. Association between IL-18, IFN-γ and TB susceptibility: a systematic review and meta-analysis. Annals Palliat Med. 2021;10(10):10878–10886. doi:10.21037/apm-21-2582
   PubMedGoogle Scholar
• Zhou Y, Zhang F, Shi H, Wu P, Zhou Y. Host biomarkers other than interferon gamma in QFT-TB supernatants for identifying active tuberculosis. Tuberculosis. 2022;136:102256. doi:10.1016/j.tube.2022.102256
   PubMed Web of Science ®Google Scholar
• Kumar N, Hissar S, Thiruvengadam K, et al. Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis. BMC Infect Dis. 2021;21(1):1055. doi:10.1186/s12879-021-06749-6
   PubMed Web of Science ®Google Scholar
• Mihret A, Bekele Y, Bobosha K, et al. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection. J Infect. 2013;66(4):357–365. doi:10.1016/j.jinf.2012.11.005
   PubMed Web of Science ®Google Scholar
• He J, Fan Y, Shen D, et al. Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls. Cytokine. 2020;135:155218. doi:10.1016/j.cyto.2020.155218
   PubMed Web of Science ®Google Scholar
• Koyuncu D, Niazi M, Tavolara T, et al. CXCL1: a new diagnostic biomarker for human tuberculosis discovered using Diversity Outbred mice. PLoS Pathogens. 2021;17(8):e1009773. doi:10.1371/journal.ppat.1009773
   PubMed Web of Science ®Google Scholar
• Selvavinayagam S, Aswathy B, Yong Y, et al. Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts-A cross-sectional study. PLOS Glob Public Health. 2023;3(11):e0002327. doi:10.1371/journal.pgph.0002327
   PubMedGoogle Scholar
• Feria M, Chang C, Ticona E, et al. Pro-inflammatory alterations of circulating monocytes in latent tuberculosis infection. Open Forum Infect Diseases. 2022;9(12):ofac629. doi:10.1093/ofid/ofac629
   PubMed Web of Science ®Google Scholar
• Essone P, Leboueny M, Maloupazoa Siawaya A, et al. M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis. Sci Rep. 2019;9(1):8201. doi:10.1038/s41598-019-44294-0
   PubMedGoogle Scholar
• Li Q, Ren W, Yuan J, et al. Significant difference in Th1/Th2 paradigm induced by tuberculosis-specific antigens between IGRA-positive and IGRA-negative patients. Front Immunol. 2022;13:904308. doi:10.3389/fimmu.2022.904308
   PubMed Web of Science ®Google Scholar
• Reichler M, Khan A, Sterling T, et al. Risk and timing of tuberculosis among close contacts of persons with infectious tuberculosis. J Infect Dis. 2018;218(6):1000–1008. doi:10.1093/infdis/jiy265
   PubMed Web of Science ®Google Scholar
• He XY, Cao MQ, Mahapatra T, et al. Burden of tuberculosis in Xinjiang between 2011 and 2015: a surveillance data-based study. PLoS One. 2017;12(11):e0187592. doi:10.1371/journal.pone.0187592
   PubMed Web of Science ®Google Scholar
• Xu J, Hu Y, Jiang W, et al. 上海市流动人口肺结核患者密切接触者结核分枝杆菌潜伏感染情况及危险因素 [Prevalence and risk factors of latent tuberculosis infection in close contacts of tuberculosis patients among non-resident populations in Shanghai, China]. Zhonghua jie he he hu xi za zhi. 2016;39(1):25–29. Chinese. doi:10.3760/cma.j.issn.1001-0939.2016.01.008
   PubMedGoogle Scholar
• Praveen V. Prevalence of LTBI among household contacts of sputum positive TB patients receiving DOTS chemotherapy. Indian J Tubercul. 2020;67(4):459–465. doi:10.1016/j.ijtb.2020.07.007
   PubMedGoogle Scholar
• MacPherson P, Lebina L, Motsomi K, et al. Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: analysis of baseline data from a cluster-randomised trial. PLoS One. 2020;15(3):e0230376. doi:10.1371/journal.pone.0230376
   PubMed Web of Science ®Google Scholar
• Fox G, Johnston J, Nguyen T, et al. Active case-finding in contacts of people with TB. Int J Tuberc Lung Dis. 2021;25(2):95–105. doi:10.5588/ijtld.20.0658
   PubMed Web of Science ®Google Scholar
• Beyanga M, Kidenya B, Gerwing-Adima L, Ochodo E, Mshana S, Kasang C. Investigation of household contacts of pulmonary tuberculosis patients increases case detection in Mwanza City, Tanzania. BMC Infect Dis. 2018;18(1):110. doi:10.1186/s12879-018-3036-6
   PubMedGoogle Scholar
• Li X, Zhong Z, Liu Y, et al. Dietary pattern characterized by a balanced diet rich in high-quality protein intake is associated with mild initial clinical manifestations in tuberculosis. Frontiers in Nutrition. 2022;9:912703. doi:10.3389/fnut.2022.912703
   PubMed Web of Science ®Google Scholar
• Cabrera Andrade B, Garcia-Perdomo H. Effectiveness of micronutrients supplement in patients with active tuberculosis on treatment: systematic review/Meta-analysis. Complementary Ther Med. 2020;48:102268. doi:10.1016/j.ctim.2019.102268
   PubMed Web of Science ®Google Scholar
• Noor S, Piscopo S, Gasmi A. Nutrients Interaction with the Immune System. Arch. Razi Inst. 2021;76(6):1579–1588. doi:10.22092/ari.2021.356098.1775
   PubMedGoogle Scholar
• Sharif K, Watad A, Bragazzi N, Adawi M, Amital H, Shoenfeld Y. Coffee and autoimmunity: more than a mere hot beverage! Autoimmunity Rev. 2017;16(7):712–721. doi:10.1016/j.autrev.2017.05.007
   PubMed Web of Science ®Google Scholar
• Kim T, Jin Y, Kim Y, et al. SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions. Autophagy. 2019;15(8):1356–1375. doi:10.1080/15548627.2019.1582743
   PubMed Web of Science ®Google Scholar
• Zhang L, Wan S, Ye S, et al. Application of IFN-γ/IL-2 FluoroSpot assay for distinguishing active tuberculosis from non-active tuberculosis: a cohort study. Clin. Chim. Acta. 2019;499:64–69. doi:10.1016/j.cca.2019.08.022
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang J, Huang H, et al. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion. BMC Infect Dis. 2019;19(1):55. doi:10.1186/s12879-018-3654-z
   PubMedGoogle Scholar
• Gopalakrishnan A, Dietzold J, Verma S, Bhagavathula M, Salgame P, Ehrt S. Toll-like receptor 2 prevents neutrophil-driven immunopathology during infection with mycobacterium tuberculosis by curtailing CXCL5 production. Infect Immun. 2019;87(3). doi:10.1128/IAI.00760-18
   PubMed Web of Science ®Google Scholar
• Barham M, Whatney W, Khayumbi J, et al. Mycobacterium tuberculosisActivation-induced marker expression identifies -specific CD4 T cells in a cytokine-independent manner in HIV-infected individuals with latent tuberculosis. ImmunoHorizons. 2020;4(10):573–584. doi:10.4049/immunohorizons.2000051
   PubMedGoogle Scholar
• Colebunders R, John L, Huyst V, Kambugu A, Scano F, Lynen L. Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources. Int J Tuberc Lung Dis. 2006;10(9):946–953.
   PubMed Web of Science ®Google Scholar
• Back Y, Bae H, Choi H, et al. Fusion of dendritic cells activating Rv2299c protein enhances the protective immunity of Ag85B-ESAT6 vaccine candidate against tuberculosis. Pathogens. 2020;9(11):865. doi:10.3390/pathogens9110865
   PubMed Web of Science ®Google Scholar
• Ma X, Yan W, Zheng H, et al. Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Research. 2015;4:4. doi:10.12688/f1000research.6003.2
   PubMedGoogle Scholar
• Wang X, Liu C, Du Y, Wang D, Zhang X. Do knowledge, attitudes, and barrier perception affect the prevention and control of healthcare-associated infections? A structural equation modelling approach. Infect Drug Resist. 2023;16:3051–3063. doi:10.2147/IDR.S409398
   PubMed Web of Science ®Google Scholar